The University of Chicago Header Logo

Connection

Mark Kozloff to Dacarbazine

Back to Details
This is a "connection" page, showing publications Mark Kozloff has written about Dacarbazine.
Mark Kozloff
Connection Strength
0.064
Dacarbazine
  1. Phase II trial of temozolomide and irinotecan as second-line treatment for advanced non-small cell lung cancer. J Thorac Oncol. 2006 Mar; 1(3):245-51.
    View in: PubMed
    Score: 0.064
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.